JPS55139320A - Bone metabolism regulator - Google Patents
Bone metabolism regulatorInfo
- Publication number
- JPS55139320A JPS55139320A JP4524479A JP4524479A JPS55139320A JP S55139320 A JPS55139320 A JP S55139320A JP 4524479 A JP4524479 A JP 4524479A JP 4524479 A JP4524479 A JP 4524479A JP S55139320 A JPS55139320 A JP S55139320A
- Authority
- JP
- Japan
- Prior art keywords
- bone metabolism
- formula
- metabolism regulator
- dihydroxycholecalciferol
- ossification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4524479A JPS55139320A (en) | 1979-04-16 | 1979-04-16 | Bone metabolism regulator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4524479A JPS55139320A (en) | 1979-04-16 | 1979-04-16 | Bone metabolism regulator |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS55139320A true JPS55139320A (en) | 1980-10-31 |
Family
ID=12713837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4524479A Pending JPS55139320A (en) | 1979-04-16 | 1979-04-16 | Bone metabolism regulator |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55139320A (ja) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58185519A (ja) * | 1982-04-15 | 1983-10-29 | Kureha Chem Ind Co Ltd | 抗高燐血症剤 |
JPS6089422A (ja) * | 1983-10-24 | 1985-05-20 | Kureha Chem Ind Co Ltd | 抗骨粗鬆症剤 |
JPS60120812A (ja) * | 1983-12-02 | 1985-06-28 | Teijin Ltd | 糖尿病性骨減少症治療剤 |
JPS61130225A (ja) * | 1984-11-29 | 1986-06-18 | Kureha Chem Ind Co Ltd | 腎性骨異栄養症における疼痛軽減剤 |
JPS61222452A (ja) * | 1985-03-15 | 1986-10-02 | イエダ・リサーチ・アンド・デベロツプメント・コンパニー・リミテツド | 骨治療用組成物 |
JPS6233A (ja) * | 1985-04-04 | 1987-01-06 | ザ、ゼネラル、ホスピタル、コ−ポレ−シヨン | 骨質量増加用医薬複合剤 |
JPS625916A (ja) * | 1985-07-01 | 1987-01-12 | エフ・ホフマンーラ ロシユ アーゲー | 製薬学的調製物 |
JPS6431722A (en) * | 1987-07-22 | 1989-02-02 | Teva Pharma | Composition of cholecalciferol derivative for treating renal bone disease |
KR950000153A (ko) * | 1993-06-21 | 1995-01-03 | 아라끼 타다시 | 신성골이영양증(Renal Osteodystrophy)의 골질량감소 억제제 |
US5540919A (en) * | 1989-09-25 | 1996-07-30 | University Of Utah Research Foundation | Method for enhancement of production of lymphokines and applications thereof |
US5753237A (en) * | 1989-09-25 | 1998-05-19 | University Of Utah Research Foundation | Method for augmenting immunological responses |
JP2014088455A (ja) * | 2006-06-21 | 2014-05-15 | Proventiv Therapeutics Llc | 二次性副甲状腺機能亢進症の治療及び予防方法 |
US10300078B2 (en) | 2013-03-15 | 2019-05-28 | Opko Ireland Global Holdings, Ltd. | Stabilized modified release vitamin D formulation and method of administering same |
US10493084B2 (en) | 2014-08-07 | 2019-12-03 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
WO2020191426A1 (en) * | 2019-03-22 | 2020-10-01 | Jake Stockfeed Pty Ltd | Horse supplement |
US11007204B2 (en) | 2006-02-03 | 2021-05-18 | Opko Renal, Llc | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
US11154509B2 (en) | 2007-04-25 | 2021-10-26 | Eirgen Pharma Ltd. | Methods for controlled release oral dosage of a vitamin D compound |
US11173168B2 (en) | 2016-03-28 | 2021-11-16 | Eirgen Pharma Ltd. | Methods of treating vitamin D insufficiency in chronic kidney disease |
US11672809B2 (en) | 2010-03-29 | 2023-06-13 | Eirgen Pharma Ltd. | Methods and compositions for reducing parathyroid levels |
US11752158B2 (en) | 2007-04-25 | 2023-09-12 | Eirgen Pharma Ltd. | Method of treating vitamin D insufficiency and deficiency |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51128417A (en) * | 1975-04-28 | 1976-11-09 | Teijin Ltd | A method for stabilizing active vitamin d3 derivatives |
JPS5326316A (en) * | 1976-08-20 | 1978-03-11 | Teijin Ltd | Drug containing active vitamin d3 derivatives and its preparation |
-
1979
- 1979-04-16 JP JP4524479A patent/JPS55139320A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51128417A (en) * | 1975-04-28 | 1976-11-09 | Teijin Ltd | A method for stabilizing active vitamin d3 derivatives |
JPS5326316A (en) * | 1976-08-20 | 1978-03-11 | Teijin Ltd | Drug containing active vitamin d3 derivatives and its preparation |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0371411B2 (ja) * | 1982-04-15 | 1991-11-13 | Kureha Chemical Ind Co Ltd | |
JPS58185519A (ja) * | 1982-04-15 | 1983-10-29 | Kureha Chem Ind Co Ltd | 抗高燐血症剤 |
JPS6089422A (ja) * | 1983-10-24 | 1985-05-20 | Kureha Chem Ind Co Ltd | 抗骨粗鬆症剤 |
JPH0132208B2 (ja) * | 1983-10-24 | 1989-06-29 | Kureha Chemical Ind Co Ltd | |
JPS60120812A (ja) * | 1983-12-02 | 1985-06-28 | Teijin Ltd | 糖尿病性骨減少症治療剤 |
JPS61130225A (ja) * | 1984-11-29 | 1986-06-18 | Kureha Chem Ind Co Ltd | 腎性骨異栄養症における疼痛軽減剤 |
JPH0372206B2 (ja) * | 1984-11-29 | 1991-11-18 | Kureha Chemical Ind Co Ltd | |
JPS61222452A (ja) * | 1985-03-15 | 1986-10-02 | イエダ・リサーチ・アンド・デベロツプメント・コンパニー・リミテツド | 骨治療用組成物 |
JPS6233A (ja) * | 1985-04-04 | 1987-01-06 | ザ、ゼネラル、ホスピタル、コ−ポレ−シヨン | 骨質量増加用医薬複合剤 |
JPH0772138B2 (ja) * | 1985-04-04 | 1995-08-02 | ザ、ゼネラル、ホスピタル、コ−ポレ−シヨン | 骨質量増加用医薬複合剤 |
JPS625916A (ja) * | 1985-07-01 | 1987-01-12 | エフ・ホフマンーラ ロシユ アーゲー | 製薬学的調製物 |
AU604534B2 (en) * | 1987-07-22 | 1990-12-20 | Teva Pharmaceutical Industries Ltd. | A combination of cholecalciferol derivatives for the treatment of renal bone disease |
JPS6431722A (en) * | 1987-07-22 | 1989-02-02 | Teva Pharma | Composition of cholecalciferol derivative for treating renal bone disease |
US5919465A (en) * | 1989-09-25 | 1999-07-06 | University Of Utah Research Foundation | Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) |
US5540919A (en) * | 1989-09-25 | 1996-07-30 | University Of Utah Research Foundation | Method for enhancement of production of lymphokines and applications thereof |
US5753237A (en) * | 1989-09-25 | 1998-05-19 | University Of Utah Research Foundation | Method for augmenting immunological responses |
KR950000153A (ko) * | 1993-06-21 | 1995-01-03 | 아라끼 타다시 | 신성골이영양증(Renal Osteodystrophy)의 골질량감소 억제제 |
US11911398B2 (en) | 2006-02-03 | 2024-02-27 | Opko Renal, Llc | Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
US11007204B2 (en) | 2006-02-03 | 2021-05-18 | Opko Renal, Llc | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
US10668089B2 (en) | 2006-06-21 | 2020-06-02 | Opko Ireland Global Holdings, Ltd. | Method of treating and preventing secondary hyperparathyroidism |
JP2014088455A (ja) * | 2006-06-21 | 2014-05-15 | Proventiv Therapeutics Llc | 二次性副甲状腺機能亢進症の治療及び予防方法 |
US9913852B2 (en) | 2006-06-21 | 2018-03-13 | Opko Ireland Global Hodlings, Ltd. | Method of treating and preventing secondary hyperparathyroidism |
US9402855B2 (en) | 2006-06-21 | 2016-08-02 | Opko Renal, Llc | Method of treating and preventing secondary hyperparathyroidism |
US11752158B2 (en) | 2007-04-25 | 2023-09-12 | Eirgen Pharma Ltd. | Method of treating vitamin D insufficiency and deficiency |
US11154509B2 (en) | 2007-04-25 | 2021-10-26 | Eirgen Pharma Ltd. | Methods for controlled release oral dosage of a vitamin D compound |
US11672809B2 (en) | 2010-03-29 | 2023-06-13 | Eirgen Pharma Ltd. | Methods and compositions for reducing parathyroid levels |
US11253528B2 (en) | 2013-03-15 | 2022-02-22 | Eirgen Pharma Ltd. | Stabilized modified release Vitamin D formulation and method of administering same |
US10350224B2 (en) | 2013-03-15 | 2019-07-16 | Opko Ireland Global Holdings, Ltd. | Stabilized modified release vitamin D formulation and method of administering same |
US10357502B2 (en) | 2013-03-15 | 2019-07-23 | Opko Ireland Global Holdings, Ltd. | Stabilized modified release vitamin D formulation and method of administering same |
US10300078B2 (en) | 2013-03-15 | 2019-05-28 | Opko Ireland Global Holdings, Ltd. | Stabilized modified release vitamin D formulation and method of administering same |
US11007205B2 (en) | 2014-08-07 | 2021-05-18 | Eirgen Pharma Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
US11738033B2 (en) | 2014-08-07 | 2023-08-29 | Eirgen Pharma Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
US10493084B2 (en) | 2014-08-07 | 2019-12-03 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
US11173168B2 (en) | 2016-03-28 | 2021-11-16 | Eirgen Pharma Ltd. | Methods of treating vitamin D insufficiency in chronic kidney disease |
WO2020191426A1 (en) * | 2019-03-22 | 2020-10-01 | Jake Stockfeed Pty Ltd | Horse supplement |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55139320A (en) | Bone metabolism regulator | |
IL78342A (en) | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof | |
MX9707535A (es) | Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario. | |
DK0517797T3 (da) | Anvendelse af D-vitaminanaloger i behandlingen af akne | |
JPS55136229A (en) | Adjustment of bone metabolism in warm-blooded animal and drug for it | |
IE791496L (en) | Fluorinated compounds of the vitamin d structure | |
AU4926690A (en) | Oxidized diphenylheteroalkanes, the preparation and use thereof | |
Chesney | Rickets: the third wave | |
Fitzpatrick et al. | Vitamin D-deficient rickets: a multifactorial disease | |
IE800619L (en) | 24, 24-difluoro-vitamin d3 derivatives | |
ZA879280B (en) | Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds | |
Underwood et al. | Metabolism of calcium in normal, rachitic and vitamin D-treated rats as evidenced by radiocalcium Ca45 studies | |
Epstein | Rantidine and confusion. | |
SE9001308L (sv) | Foerfarande foer att behandla och foerebygga foertvining av bensubstans | |
SE8102161L (sv) | "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra | |
DE3650735T2 (de) | Verwendung von Cholin oder Cholin freisetzenden Verbindungen zur Verringerung der Empfingdung von Ermüdung | |
JPS5524105A (en) | Method and agent for control of calcium metabolism of warm-blooded animal | |
Hill et al. | Treatment of hypoparathyroidism with 1, 25‐dihydroxycholecalciferol | |
JPS56103114A (en) | Drug for osteoporosis comprising 24r- hydroxycholecalciferol | |
AU563733B2 (en) | Use of 24,24-difluoro-1alpha,25-dihydroxy-cholecalciferol to treat osteoporosis and prevent milk fever | |
DE59001796D1 (de) | Verwendung einer hydroxyoctadecadiensaeure, deren zur ketoform oxidierte saeure sowie deren derivate zur therapie oestrogenabhaengiger krankheiten, sowie pharmazeutische zusammensetzungen, die diese enthalten. | |
LINDHOLM et al. | New Bone Formation and Parathyroid Activity Effected by 1 α-Hydroxyvitamin D3 | |
Gunnes | Determinants of beak bone mass and bone mineralization rates in 470 healthy children, adolescents and young adults: A prospective study | |
Prentice et al. | Post-renal transplant limb pain syndrome: A new entity? | |
St John et al. | GFR, acidosis and 25 (OH) vitamin D status determine parathyroid hormone and calcitriol concentrations in mild and moderate renal impairment |